Literature DB >> 16831922

Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system.

Xin-Hua Liu1, Alexander Kirschenbaum, Shen Yao, Alice C Levine.   

Abstract

The OPG/RANKL/RANK system regulates osteoclastogenesis. Both cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) and interleukin-6 (IL-6) are reported to induce osteoclast differentiation. The mechanisms underlying these signaling pathways on the OPG/RANKL/RANK system are not fully understood. We herein demonstrate that COX-2 and PGE2 stimulated osteoclastogenesis through inhibition of OPG secretion, stimulation of RANKL production by osteoblasts, and upregulation of RANK expression in osteoclasts. PGE2 also stimulated IL-6 production, and IL-6, in turn, increased PGE2 secretion, COX-2, and EP4/EP2 expression in bone cells. These findings provide evidence of interactive effect of PGE2 and IL-6 signaling pathways in osteoclastogenesis via effect on the OPG/RANKL/RANK system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831922     DOI: 10.1196/annals.1346.047

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  29 in total

1.  siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Pharm Res       Date:  2010-03-24       Impact factor: 4.200

Review 2.  [Bone metabolism: molecular mechanisms].

Authors:  E Neumann; G Schett
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

3.  Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain.

Authors:  Tomohito Akiyama; Yoichi Miyamoto; Kentaro Yoshimura; Atsushi Yamada; Masamichi Takami; Tetsuo Suzawa; Marie Hoshino; Takahisa Imamura; Chie Akiyama; Rika Yasuhara; Kenji Mishima; Toshifumi Maruyama; Chikara Kohda; Kazuo Tanaka; Jan Potempa; Hisataka Yasuda; Kazuyoshi Baba; Ryutaro Kamijo
Journal:  J Biol Chem       Date:  2014-04-22       Impact factor: 5.157

Review 4.  Subchondral bone and osteoarthritis: biological and cellular aspects.

Authors:  Y Henrotin; L Pesesse; C Sanchez
Journal:  Osteoporos Int       Date:  2012-11-22       Impact factor: 4.507

5.  Effect of low-magnitude, high-frequency vibration on osteocytes in the regulation of osteoclasts.

Authors:  Esther Lau; Saja Al-Dujaili; Axel Guenther; Dawei Liu; Liyun Wang; Lidan You
Journal:  Bone       Date:  2010-03-06       Impact factor: 4.398

6.  Connexin 43 channels are essential for normal bone structure and osteocyte viability.

Authors:  Huiyun Xu; Sumin Gu; Manuel A Riquelme; Sirisha Burra; Danielle Callaway; Hongyun Cheng; Teja Guda; James Schmitz; Roberto J Fajardo; Sherry L Werner; Hong Zhao; Peng Shang; Mark L Johnson; Lynda F Bonewald; Jean X Jiang
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

7.  A DNA segment spanning the mouse Tnfsf11 transcription unit and its upstream regulatory domain rescues the pleiotropic biologic phenotype of the RANKL null mouse.

Authors:  Melda Onal; Kathleen A Bishop; Hillary C St John; Allison L Danielson; Erin M Riley; Marilina Piemontese; Jinhu Xiong; Joseph J Goellner; Charles A O'Brien; J Wesley Pike
Journal:  J Bone Miner Res       Date:  2015-05       Impact factor: 6.741

Review 8.  [Inflammation and bone metabolism].

Authors:  E Neumann; U Müller-Ladner; K W Frommer
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

Review 9.  Understanding and targeting osteoclastic activity in prostate cancer bone metastases.

Authors:  J L Sottnik; E T Keller
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

10.  Prostaglandin expression profile in hypoxic osteoblastic cells.

Authors:  Christina M Lee; Damian C Genetos; Alice Wong; Clare E Yellowley
Journal:  J Bone Miner Metab       Date:  2009-05-28       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.